Meiji Yasuda Asset Management Co Ltd. Buys 265 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Meiji Yasuda Asset Management Co Ltd. increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,132 shares of the medical equipment provider’s stock after buying an additional 265 shares during the period. Meiji Yasuda Asset Management Co Ltd.’s holdings in Intuitive Surgical were worth $9,986,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of ISRG. Howard Capital Management Group LLC boosted its holdings in shares of Intuitive Surgical by 4.5% during the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after buying an additional 92 shares in the last quarter. Principal Financial Group Inc. lifted its position in Intuitive Surgical by 1.5% during the 3rd quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock valued at $295,938,000 after acquiring an additional 9,194 shares during the period. Quest Partners LLC bought a new stake in Intuitive Surgical during the third quarter worth about $173,000. Great Valley Advisor Group Inc. increased its stake in shares of Intuitive Surgical by 2.7% during the third quarter. Great Valley Advisor Group Inc. now owns 2,543 shares of the medical equipment provider’s stock valued at $1,249,000 after purchasing an additional 66 shares in the last quarter. Finally, Algert Global LLC purchased a new position in shares of Intuitive Surgical during the third quarter valued at approximately $1,988,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Up 3.3 %

Shares of NASDAQ:ISRG opened at $508.58 on Tuesday. The firm’s 50 day moving average price is $561.62 and its 200-day moving average price is $532.25. The stock has a market capitalization of $181.15 billion, a PE ratio of 79.34, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 33,754 shares of company stock worth $17,691,621. Company insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently weighed in on ISRG shares. Royal Bank of Canada upped their price target on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Barclays increased their target price on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Citigroup upped their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Bernstein Bank raised their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. Finally, Leerink Partners upped their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.